Journal of Molecular Liquids, Год журнала: 2023, Номер 395, С. 123911 - 123911
Опубликована: Дек. 28, 2023
Язык: Английский
Journal of Molecular Liquids, Год журнала: 2023, Номер 395, С. 123911 - 123911
Опубликована: Дек. 28, 2023
Язык: Английский
Current Neuropharmacology, Год журнала: 2024, Номер 23(3), С. 317 - 328
Опубликована: Май 6, 2024
Alzheimer's disease (AD) is a neurodegenerative condition that affects the elder population and linked to behavioral instability cognitive decline. Only few drugs are approved for clinical management of AD. Volatile oils their components exhibit diverse pharmacological potentials, including neuroprotective properties. The current study aimed evaluate isoeugenol's potentials against impairments caused by scopolamine. Standard protocols were followed in In-vitro antioxidant, cholinesterase inhibitory molecular docking assays. Isoeugenol was initially evaluated antioxidant potential using DPPH ABTS free radicals scavenging Subsequently, AChE/BChE inhibition studies performed following Ellman's assay. To assess compound's binding effectiveness at enzymes' target site, it docked sites cholinesterase. effect isoeugenol supplementation on scopolamine-induced amnesia assessed Shallow Water Maze (SWM), Y-Maze Elevated Plus (EPM) tests. In assays, exhibited considerable efficacy with IC50 38.97 43.76 μg/mL, respectively. revealed 78.39 ± 0.40% 67.73 0.03% inhibitions AChE BChE, respectively, 1 mg/ml concentration. studies, score -12.2390, forming two hydrogen bonds active site residues AChE. Further, -10.1632, binds adequately BChE enzyme via arene-hydrogen interactions one bond. offered protection memory deficits improved special rodents.
Язык: Английский
Процитировано
1Russian Journal of Bioorganic Chemistry, Год журнала: 2024, Номер 50(3), С. 934 - 948
Опубликована: Июнь 1, 2024
Язык: Английский
Процитировано
1RSC Advances, Год журнала: 2024, Номер 14(48), С. 35400 - 35423
Опубликована: Янв. 1, 2024
The study of quinoxalines as nitrogen-rich heterocyclic compounds has garnered substantial interest within scientific research owing to their multidimensional functionalization capabilities and significant biological activities. scope encompasses application potent antiviral agents, particularly the domain respiratory pathologies-a topic pivotal concern in this comprehensive review. They have several prominent pharmacological effects, such potential influenza inhibitors, anti-SARS coronavirus anti-SARS-CO-2 miscellaneous As a result, some literature described many these using various synthetic methods for mentioned effects. In present review, we provided insight into quinoxaline synthesis, structure-activity relationship (SAR), activities, along with compilation recent studies. article further encapsulates gamut past ongoing efforts design exploration scaffolds, pronounced emphasis on strategic deployment against viral pandemics, contextualized tapestry COVID-19 outbreak. This illuminates quintessential role armamentarium pathogens provides platform development next-generation agents.
Язык: Английский
Процитировано
1Bioengineering, Год журнала: 2023, Номер 10(8), С. 961 - 961
Опубликована: Авг. 14, 2023
SARS-CoV-2 exploits the homotrimer transmembrane Spike glycoproteins (S protein) during host cell invasion. The Omicron XBB subvariant, delta, and prototype receptor-binding domain show similar binding strength to hACE2 (human Angiotensin-Converting Enzyme 2). Here we utilized multiligand virtual screening identify small molecule inhibitors for their efficacy against virus using QPLD, pseudovirus ACE2 Inhibition -Time Resolved Forster/Fluorescence energy transfer (TR-FRET) Assay Screening, Molecular Dynamics simulations (MDS). Three hundred fifty thousand compounds were screened macrodomain of nonstructural protein 3 SARS-CoV-2. Using TR-FRET Assay, filtered out two 10 that had no reported activity in vitro screen S1: assay. percentage inhibition at 30 µM was found be 79% “Compound F1877-0839” 69% F0470-0003”. This first its kind study identified “FILLY” pocket macrodomains. Our 200 ns MDS revealed stable poses both leads. They can used further development preclinical candidates.
Язык: Английский
Процитировано
3Current Computer - Aided Drug Design, Год журнала: 2023, Номер 20(7), С. 1113 - 1129
Опубликована: Окт. 19, 2023
In China, Niuxi-Mugua formula (NMF) has been widely used to prevent and treat coronavirus disease 2019 (COVID-19). However, the mechanism of NMF for treating COVID-19 is not yet fully understood.
Язык: Английский
Процитировано
0Journal of Molecular Liquids, Год журнала: 2023, Номер 395, С. 123911 - 123911
Опубликована: Дек. 28, 2023
Язык: Английский
Процитировано
0